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Abstract 
Traits presumed to reflect dopaminergic reward and prefrontal executive systems functioning 
were assessed in 100 clients undergoing residential treatment for substance dependence and a 
community sample of 107 social drinkers. All participants completed self-report measures of 
impulsivity, alexithymia, frontal systems dysfunction, sensitivity to rewards and 
punishments, dispositional mindfulness, alcohol use, illicit drug use, mood and demographic 
characteristics. The percentage of in-patients meeting the criterion for alexithymia was more 
than twice as high as in the community sample (p < .0001). Multivariate analysis of 
covariance controlling for age, education, head injury and gender revealed significant 
differences (p < .0001) between clinical and community samples such that clients scored 
higher on negative moods, frontal systems dysfunction, reward sensitivity, punishment 
sensitivity and impulsivity, and lower on dispositional mindfulness. Time in treatment was 
correlated only with negative mood, supporting the stability of the trait measures; controlling 
for negative mood eliminated group differences on punishment sensitivity and mindfulness 
only. Results are consistent with the notion that addiction is linked to reward sensitivity and 
frontal lobe deficits, with associated implications. 
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1. Introduction   
In recent decades biological perspectives on addiction have emphasised the 
intertwined roles of (1) the subcortical dopaminergic reward system as a driver of excessive 
substance use (Koob & LeMoal, 1997; Volkow, Fowler & Wang, 2004; Wise, 1998) and (2) 
prefrontal cortex dysfunction as the basis of the impaired self-control that characterises 
addictive behaviour and relapse (Lyvers, 2000; Schoenbaum & Shaham, 2008; Spinella, 
2003; Volkow & Li, 2004). Traits presumed to reflect the functioning of these brain systems 
include reward sensitivity, often interpreted to index the motivational influence of the 
dopaminergic reward or behavioural activation system (BAS; Gray, 1987; Torrubia, Avila, 
Molto & Caseras, 2001), and traits such as impulsivity, disinhibition, executive deficit and 
alexithymia (difficulties with identifying and describing one’s emotions), which have been 
linked to abnormalities of prefrontal cortex function as well as risky or problematic substance 
use (Berthoz et al., 2002; Chen et al., 2007; Dawe, Gullo & Loxton, 2004; Lyvers, Duff, 
Basch & Edwards, 2012; Pinard, Negrete, Annable, & Audet, 1996;  Spinella, 2004; 
Thorberg et al., 2009). A combination of inherently high reward sensitivity and deficient 
executive self-regulation appears to be significantly associated with risky substance use and 
addiction (Dawe & Loxton, 2004; Dolan, Bechara, & Nathan, 2008; Ivanov, Schulz, London 
& Newcorn, 2008; Lyvers, Carlopio, Bothma & Edwards, 2013; Lyvers, Jamieson & 
Thorberg, 2013).  Recent attention has also focused on the possible role of mindfulness as a 
protective factor against addiction and relapse (Bowen & Vieten, 2012). Mindfulness, defined 
as “awareness and attention to present events and experiences” (Brown & Ryan, 2003, p. 
824), appears to reflect higher-order, meta-cognitive functioning (Chambers et al., 2009) and 
is inversely related to impulsivity, alexithymia, and indices of frontal systems dysfunction 
(Lyvers, Makin, Toms, Thorberg & Samios, in press). Mindfulness thus appears to be another 
aspect of executive cognition. 
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Based on the notion that addiction is associated with inherently high BAS 
responsiveness as well as deficiencies in aspects of prefrontal cortex function such as impulse 
control, mood regulation, and executive cognition (Dawe & Loxton, 2004; Dolan et al., 2008; 
Ivanov et al., 2008), the present study examined self-report indices of reward sensitivity, 
frontal systems dysfunction, impulsivity, alexithymia, and mindfulness in abstinent, 
detoxified clients undergoing in-patient treatment for substance dependence and in a 
comparison sample of non-intoxicated social drinkers from the local community. These 
measures had previously shown significant correlations with risky substance use in non-
clinical community samples for a variety of substances (Lyvers, Carlopio et al., 2013; Lyvers, 
Jamieson et al., 2013; Lyvers et al., 2012; Pinard et al., 1996) but had not previously been 
examined together in a clinical sample of substance dependent clients. Other variables that 
were previously found to influence responding on at least some of the measures of interest to 
the present investigation were also assessed in the present study and their influence controlled 
via covariate analysis. The clinical sample was expected to score higher than the community 
sample on measures of negative moods, especially among those early in treatment; but 
independent of transient mood differences, indices of more stable traits reflecting inherent 
executive dysregulation (prefrontal cortex) and reward sensitivity (BAS) were expected to be 
significantly elevated in the addicts, in line with theoretical expectations. 
 2. Method 
2.1. Participants 
Substance dependent clients from three Therapeutic Community (TC) addiction 
treatment centres in southeastern Queensland, Australia, were recruited for the present study 
over a 10 week period. A $40 gift voucher was offered as an incentive for participation. 
Abstinence was confirmed by random urine testing. Residential treatment programs were for 
a minimum of six months. All client participants were self-referred, had completed more than 
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14 days in treatment to rule out an influence of detoxification or acute withdrawal on 
responses, and were not diagnosed with a comorbid neurological or psychological disorder 
(these were stated criteria for participation). The final clinical sample consisted of 100 TC in-
patients undergoing treatment for substance (alcohol and/or illicit drug) dependence (58 
males, 42 females; age range 18-63 years, M = 32.47, SD = 11.26) who on average had been 
in treatment for 108 days with a range of 17-612 days. The community sample was recruited 
through advertisements in a local newspaper over the same 10 week period. The 
advertisements asked for social drinkers who were not currently undergoing treatment for any 
neurological or psychological disorder. A $40 gift voucher was specified as an incentive for 
participation. Interested community members were instructed to attend the university campus 
where the testing would occur at a pre-arranged time and place. The final community sample 
consisted of 107 social drinker volunteers from the local southeast Queensland community 
(43 males, 64 females; age range 18-48 years, M = 26.65, SD = 6.50). Volunteers from either 
group were excluded from the final sample if their responses on a demographics and 
screening questionnaire indicated a current neurological condition (2 addict volunteers). In 
addition community participants were excluded if their questionnaire responses or alcohol 
breath test indicated recent intoxication (5 volunteers); if their scores on the Alcohol Use 
Disorders Identification Test (AUDIT; Babor, de la Fuente, Saunders & Grant, 1992) or the 
Drug Use Disorders Identification Test (DUDIT; Berman, Bergman, Palmstierna & Schlyter, 
2003) indicated likely substance dependence (6 volunteers); or if their demographic 
questionnaire responses indicated previous treatment for a substance problem (1 volunteer). 
The final samples described above also reflect the exclusion of 8 multivariate outliers 
identified via Mahalanobis Distance using boxplots. No participants in either sample were of 
Aboriginal background. 
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In the clinical sample 21% indicated that alcohol was their primary problem, 11% 
indicated stimulants (cocaine or amphetamines), 5% indicated cannabis and 3% indicated 
opiates such as heroin. The remainder (60%) indicated that their problem involved multiple 
substances, generally combinations of cannabis, stimulants and/or opiates with alcohol. All 
participants provided informed consent prior to participation and could withdraw from the 
study at any time without penalty. Participants were instructed to not provide identifying 
information on their questionnaires in order to ensure anonymity. The research protocol was 
approved by the university ethics committee and treatment centres prior to data collection.  
2.2. Procedure 
Clients were recruited to complete the pen and paper survey by a staff member at the 
addiction treatment facility. They were asked to place the completed survey in a provided 
envelope and seal it when finished. The staff member then collected the sealed envelopes and 
passed them on to the researchers. Community participants completed the same survey in a 
designated testing room at a local university. They were asked to place the completed survey 
in a provided envelope, seal it and hand it to one of the researchers when finished. Survey 
completion required approximately 30-45 minutes. 
2.3. Materials 
The following questionnaires were administered to all participants. 
 2.3.1. A Demographics questionnaire asked for participant age, gender, age at onset 
of drinking/drug use, years of education, neurological status, current or previous treatment for 
a substance problem or other psychological disorder, number of days in treatment (clinical 
sample only), whether they had ever suffered a serious head injury, and recent alcohol or 
drug use. 
2.3.2. The Depression Anxiety Stress Scales -21 (DASS-21; Lovibond & Lovibond, 
1995) is a 21-item self-report questionnaire consisting of three scales (each with 7 items) 
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designed to measure the emotional states of depression (e.g., “I felt down-hearted and blue”), 
anxiety (e.g., “I felt scared without any good reason”), and stress (e.g., “I found it hard to 
wind down”) upon reflection of the prior week. Items are rated on a 4-point Likert scale, 
ranging from 0 = did not apply to me at all, to 3 = applied to me very much or most of the 
time. Items are summed within each scale, with higher scores indicating higher levels of 
depression, anxiety, and stress. In the present study Cronbach’s alpha for the overall DASS-
21 was .96. 
2.3.3. The Sensitivity to Punishment and Sensitivity to Reward Questionnaire 
(SPSRQ; Torrubia et al., 2001) is comprised of two subscales, Sensitivity to Punishment (SP) 
and Sensitivity to Reward (SR). Each subscale has 24 items measuring an individual’s 
motivational propensity to engage in either approach (SR) or avoidance (SP) behaviour in the 
presence of either rewarding or punishing stimuli, respectively. Items are answered via 
dichotomous yes (1) or no (0) responses, which are summed for each subscale. The SPSRQ is 
based on Gray’s (1987) Reinforcement Sensitivity Theory (RST), such that the SR scale was 
designed to evaluate the Behavioural Activation System (BAS) and the SP scale was 
designed to evaluate the Behavioural Inhibition System (BIS). The SPSRQ has been 
established as a valid measure of the BAS and BIS components of RST (Caseras, Avila, & 
Torrubia, 2003; Loxton & Dawe, 2001). In the present study Cronbach’s alpha was .81 for 
the SR scale and .85 for SP. 
2.3.4. The Mindful Attention Awareness Scale (MAAS; Brown & Ryan, 2003) is a 15- 
item self-report measure of dispositional mindfulness. Items are negatively worded as Brown 
and Ryan (2003) felt statements reflecting states of ‘‘mindlessness” were “more accessible to 
most individuals, given that mindless states are much more common than mindful states” (p. 
826). Answers are given on a 6-point Likert scale, where 1 = almost always and 6 = almost 
never. Questions ask about awareness and attention, e.g., “I find it difficult to stay focused on 
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what’s happening in the present,” “I do jobs or tasks automatically, without being aware of 
what I’m doing.” Higher scores indicate higher trait mindfulness. A single factor solution was 
yielded from a sample of 727 university students (MacKillop & Anderson, 2007). MAAS 
scores have shown a positive association with prefrontal cortex activation and a negative 
relationship with amygdala activation (Creswell et al., 2007), in line with theoretical 
expectations. In the present study Cronbach’s alpha for the MAAS was .91. 
2.3.5. The Frontal Systems Behavior Scale (FrSBe; Grace & Malloy, 2001) is a 46-
item questionnaire designed to measure neurobehavioral traits related to dysfunction in three 
key prefrontal systems: the anterior cingulate (Apathy subscale, 14 items; e.g., ‘Sit around 
doing nothing’), orbitofrontal cortex (Disinhibition subscale, 15 items; e.g., “Do or say 
embarrassing things”), and dorsolateral prefrontal cortex (Executive Dysfunction subscale, 17 
items; e.g., “Repeat certain actions or get stuck on certain ideas”).  For brain injured patients 
the FrSBe is used to assess changes in behaviour by obtaining pre- and post-lesion ratings on 
a 5-point Likert scale (1 = almost never, 2 = seldom, 3 = sometimes, 4 = frequently, 5 = 
almost always), however in the present study only self-ratings of current behavioral 
functioning were obtained as in previous work conducted on non-brain-injured samples (e.g., 
Lyvers et al, 2012; Spinella, 2003; Stout et al., 2003). The first 32 items represent deficits and 
are positively phrased, whereas the last 14 items are negatively phrased and reverse scored. 
Items are summed with higher ratings indicating higher levels of impairment for the 
subscales as well as the total score. In the present study Cronbach’s alpha for the total FrSBe 
was .92. 
2.3.6. The Barratt Impulsiveness Scale (BIS-11; Patton et al., 1995) is a 30-item self-
report scale designed to measure trait impulsivity. Answers are given on a 4-point Likert 
scale (1 = rarely/never to 4 = almost always/always) to questions reflecting cognitive 
instability and inattention (8 items, e.g., “I don’t pay attention”), motor impulsiveness (11 
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items, e.g., “I do things without thinking”), and non-planning impulsivity (11 items, e.g., “I 
plan tasks carefully,” reverse scored). Items are summed to produce an overall score, where 
higher scores indicate greater impulsiveness. Total scores can range from 30 to 120. 
Convergent validity was established with neuropsychological measures that have shown 
sensitivity to prefrontal cortex dysfunction (Spinella, 2004). In the present study Cronbach’s 
alpha for the total BIS-11 was .81. 
2.3.7. The Toronto Alexithymia Scale-20 (TAS-20; Bagby, Parker & Taylor, 1994) is a 
20-item self-report questionnaire used to assess trait levels of alexithymia. Items are rated on 
a 5-point Likert scale (1 = strongly agree to 5 = strongly disagree) and summed within each 
subscale and then overall to create total scores that range from 20 to 100, with higher scores 
indicating greater levels of alexithymia. Cut-off scores have been empirically derived for the 
TAS-20, whereby > 61 = alexithymia and < 51 = no alexithymia (Bagby, Taylor & Parker, 
1994). The TAS-20 has sound validity and reliability (Thorberg et al., 2010) as well as a 
confirmed three factor structure supported in clinical (Swift, Stephenson, & Royce, 2006) as 
well as non-clinical (Parker, Taylor, & Bagby, 2003) samples: difficulty identifying feelings 
(DIF; e.g., “I have feelings that I can’t quite identify”), difficulty describing feelings (DDF; 
e.g., “People tell me to describe my feelings more”), and externally-oriented thinking (EOT; 
e.g., “I feel close to someone, even in moments of silence,” reverse-scored). In the present 
study Cronbach’s alpha for the TAS-20 was .78. 
2.3.8. The Alcohol Use Disorders Identification Test (AUDIT; Babor et al., 1992) is a 
10 item self-report survey used to identify low-risk, hazardous, harmful and dependent 
drinking in adolescents and adults. Response options are based on a Likert-type scale ranging 
from 0 to 4. Three items measure alcohol consumption, e.g., “In the past week, how often did 
you have a drink containing alcohol?” Three items assess alcohol dependence, e.g., “How 
often, during the past year, have you found that you were not able to stop drinking once you 
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had started?” Four items evaluate alcohol-related harm, e.g., “How often during the past year 
have you had a feeling of guilt or remorse after drinking?” Scores are calculated by 
summation of all 10 items and can range between 0 and 40. Scores between 0 and 7 are 
considered “Low Risk,” a score between 8 and 15 suggests “Hazardous” drinking and a score 
of 16 or above indicates “Harmful” drinking. A score of 4 or higher on the combined 
dependence items suggests likely alcohol dependence, as does a total score of 20 or higher 
(Babor et al., 1992). AUDIT was used in the present study to identify and remove any 
community participants with likely alcohol dependence. TC clients were instructed to base 
their AUDIT responses on their drinking behaviour prior to admission into treatment. In the 
present study Cronbach’s alpha for the AUDIT was .95. 
2.3.9. The Drug Use Disorders Identification Test (DUDIT; Berman et al., 2003) was 
developed as a parallel measure to the AUDIT for drugs other than alcohol, provides a list of 
such drugs, and has similar items and scoring procedures to the AUDIT.  Total scores can 
range from 0 to 44. A total score of 25 or higher suggests likely drug dependence (Berman et 
al., 2003). DUDIT was used in the present study to identify and remove any community 
participants with likely drug dependence. TC clients were instructed to base their DUDIT 
responses on their drug using behaviour prior to admission into treatment. In the present 
study Cronbach’s alpha for the DUDIT was .98. 
3. Results  
3.1. Alexithymia. Clinical status was significantly associated with alexithymia as  
defined by TAS-20 cut-off, χ2(2) = 15.92, p <  .0001. Of the clinical sample of 100 in-
patients, 40 (i.e., 40%) were defined as alexithymic by TAS-20 compared to only 20 out of 
107 (i.e., 18.69%) of the community sample. Alexithymia was not associated with gender 
overall, p = .99.  
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3.2. Treatment Duration. In the clinical sample, number of days in TC treatment 
ranged from 17 to 612 days (M = 108 days) and was examined using Pearson correlations in 
relation to the questionnaire measures. As expected the only variables that were significantly 
correlated with number of days in treatment were the DASS negative mood scales: 
Depression, r(100) =  -.27, p = .006; Anxiety, r(100) = -.28, p = .004; and Stress, r(100) =  
-.28, p = .005. Depression, anxiety and stress decreased as a function of days in treatment. No 
other variables - neither BIS-11, TAS-20, FrSBe scales, SR, SP nor MAAS – correlated with 
days in treatment (all p > .20), suggesting that these indexed relatively stable traits in this 
sample. 
 3.3. Intercorrelations. Intercorrelations for the entire sample are shown in Table 1. As 
can be seen in the table, each trait measure was significantly correlated with AUDIT and 
DUDIT scores as well as the DASS mood scales and most trait measures. The same pattern 
of correlations was apparent across samples and genders.  
3.4. Group Comparisons. Clinical and community samples significantly differed on 
demographic variables, hence the potential influence of these was controlled via covariate 
analysis.  There were relatively more men in the clinical sample (58%) than in the community 
sample (40%), χ2(1) =  6.57, p = .01. The clinical sample tended to be older (M = 32.47 years, 
SD = 11.26) than the community sample (M = 26.65 years, SD = 6.50), F(1, 205) = 21.05, p < 
.0001. The community sample had completed significantly more years of education (M = 
14.03 years, SD = 2.88) than the clinical sample (M = 11.02 years, SD = 2.73), F(1, 205) = 
59.43, p < .0001. More participants in the clinical sample reported ever having suffered a 
serious head injury (29%) than in the community sample (2%), χ2(1) =  29.88, p < .0001. 
Thus age, education level and past head injury were included as covariates in a 2 (clinical vs. 
community) X 2 (male vs. female) multivariate analysis of covariance (MANCOVA) on the 
DASS scales, FrSBe scales, SPSRQ scales, MAAS, and BIS-11. Levene’s Test was 
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significant (p < .05) for DASS Depression and Anxiety as well as BIS-11, so the analysis was 
conducted again using square root transformations for Depression and Anxiety and a log 10 
transformation for BIS-11; this reduced (BIS-11) or eliminated (Depression, Anxiety) the 
significant Levene’s Test results for these variables without altering the results of the 
MANCOVA, hence MANCOVA results for untransformed variables are reported here.   
The overall multivariate effect of sample (clinical vs. community) was significant 
according to Pillai’s Trace, F(7, 194) = 16.16, p < .0001, η2 = .37, observed power = 1. 
Univariate differences were significant at p < .0001 for all dependent measures with η2 
ranging from .07 to .30 indicating medium to large effect sizes. Table 2 shows that, compared 
to the community sample, the clinical sample had higher levels of depression, anxiety, stress, 
impulsivity, reward sensitivity, punishment sensitivity, disinhibition, apathy, and executive 
dysfunction, and lower levels of dispositional mindfulness. This was after controlling for the 
contributions of age, gender, education level and past serious head injury status to group 
differences. The overall sample X gender interaction was not significant, F(7, 194) = 1.27, p 
= .27. However the overall multivariate effect of gender was significant, F(7, 194) = 3.80, p = 
.001, with a univariate difference for SP, F(1, 200) = 13.01, p < .0001. Consistent with 
previous work (e.g., Lyvers et al., 2012), women scored higher on SP overall (M = 12.51, SD 
= 5.24) than men (M = 10.66, SD = 5.67). 
Table 2 also shows group results for AUDIT and DUDIT. As expected, responses of 
clients on both measures were consistent with substance dependence (see Table 2), whereas 
for the community sample DUDIT scores averaged slightly above 0 with a range of 0 to 16, 
and AUDIT scores averaged just above the cut-off between Low Risk and Hazardous 
Drinking and ranged from 1 to 18.   
Given that DASS scores declined in relation to time in treatment in the clinical sample 
as described above, the MANCOVA was conducted a second time with a composite DASS 
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score as an additional covariate to see if any of the above group differences changed after 
controlling for transient negative mood. Group differences remained significant at the 
multivariate (p < .0001) and univariate levels (p < .05 to p < .0001) in this analysis with the 
exceptions of SP (p = .17) and MAAS (p = .26) which were highly correlated with the DASS 
scales (see Table 1). 
4. Discussion 
 As expected the percentage of addicts defined as alexithymic by TAS-20 cut-off was 
more than twice as high as in the community sample, consistent with previous work showing 
associations between alexithymia and risky or problematic substance use (Lyvers, Carlopio et 
al., 2013; Lyvers, Jamieson et al., 2013; Pinard et al., 2008; Thorberg et al., 2009). The other 
trait measures also differed in expected ways between samples, consistent with the notion that 
addiction is associated with elevated reward sensitivity and deficient executive self-regulation 
as mediated by corresponding brain systems (BAS and prefrontal cortex respectively) (Dawe 
et al., 2004; Dolan et al., 2008; Ivanov et al., 2008; Lyvers et al., 2012). Self-reported levels 
of negative mood were lower in clients who had been in addiction treatment longer, but the 
primary trait indices of interest still showed significant group differences even after 
controlling for mood – with the exceptions of punishment sensitivity and mindfulness, which 
were highly correlated with the DASS mood index. Indices of impulsivity, reward sensitivity, 
apathy, disinhibition and executive dysfunction all remained significantly higher in the 
clinical sample than in the community sample even after controlling for negative moods, in 
addition to controlling for potential contributions of differences in age, education, head injury 
and gender to group differences, and did not vary in relation to duration of treatment (which 
ranged from 17 to 612 days) in the clinical sample.  
4.1. Conclusions  
Indices of traits presumed to reflect the intertwined functioning of the subcortical  
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dopaminergic reward and prefrontal cortical executive systems showed expected differences 
between in-patient and community samples that are likely to have predated substance use to a 
significant extent - though a sustained impact of addictive drugs on the brain is a competing 
account that cannot be excluded (Crews, He & Hodge, 2007; Lyvers, 2000; Volkow et al., 
2004). Irrespective of the basis of such differences, the present findings do reinforce a need to 
identify and target client characteristics that may be likely to promote addiction and relapse, 
such as alexithymia, impulsivity and executive dysfunction, in addition to dealing with 
negative mood issues during treatment for substance dependence. For example, TC client 
training in skills such as executive self-monitoring, emotional awareness and impulse control   
may prove beneficial (Alfonso et al., 2011; Thorberg et al., 2009). The present findings also 
point to the need for longitudinal studies to disentangle the roles of pre-drug personality 
versus drug use history to client characteristics associated with addiction, as well as the 
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